Can you provide the average price target for EXELIXIS INC stock?
27 analysts have analysed EXEL and the average price target is 47.77 USD. This implies a price increase of 7.88% is expected in the next year compared to the current price of 44.28.
EXELIXIS INC (EXEL) Forecast, Price Target & Analyst Ratings
NASDAQ:EXEL • US30161Q1040
Current stock price
44.28 USD
-1.58 (-3.45%)
At close:
44.28 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXELIXIS INC (EXEL).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.73
- Revenue Estimate
- 619.87M
Price Target Details & History
Consensus Price Target and Range
Mean target
$47.77
Upside
+ 7.88%
From current price of $44.28 to mean target of $47.77, Based on 27 analyst forecasts
Low
$35.35
Median
$48.96
High
$63.00
Price Target Revisions
1 Month
-0.71%
3 Months
3.44%
Price Target Summary
27 Wall Street analysts provided a forecast for the next 12 months for EXEL. The average price target is 47.77 USD. This implies a price increase of 7.88% is expected in the next year compared to the current price of 44.28.
The average price target has been revised upward by 3.44% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
74.81%
EXEL was analyzed by 27 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about EXEL.
In the previous month the buy percentage consensus was at a similar level.
EXEL was analyzed by 27 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-02-11 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-11 | Stifel | Maintains | Hold -> Hold |
| 2026-02-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-02-02 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-08 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2026-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-05 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-03 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-10-21 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-10-21 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-10-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-21 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-17 | Barclays | Initiate | Equal-Weight |
| 2025-09-17 | Goldman Sachs | Initiate | Buy |
| 2025-09-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.73
- Revenue Estimate
- 619.87M
- Revenue Q2Q
- 11.60%
- EPS Q2Q
- 33.56%
- Number of Analysts
- 21
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-3.30%
EPS (1 Month)
0.65%
EPS (3 Months)
-5.40%
Next Earnings Summary
EXEL is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.73 USD and the consensus revenue estimate is 619.87M USD.
The next earnings revenue estimate has been revised downward by 3.3% in the past 3 months.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.83B 13.60% | 2.169B 18.49% | 2.32B 6.98% | 2.637B 13.66% | 2.99B 13.39% | 3.324B 11.17% | 3.551B 6.83% | 3.231B -9.01% | 2.988B -7.52% | 3.019B 1.04% | 3.184B 5.47% | |
| EBITDA YoY % growth | 196.602M -11.60% | 718.752M 265.59% | 921.756M 28.24% | 1.107B 20.10% | 1.272B 14.91% | 1.569B 23.35% | 652.8M -58.39% | 672.18M 2.97% | 679.32M 1.06% | N/A | N/A | |
| EBIT YoY % growth | 170.885M -15.19% | 689.949M 303.75% | 892.701M 29.39% | 1.019B 14.15% | 1.209B 18.65% | 1.451B 20.02% | 1.787B 23.16% | 1.674B -6.32% | 1.33B -20.55% | 1.38B 3.76% | 1.687B 22.25% | |
| Operating Margin | 9.34% | 31.81% | 38.48% | 38.64% | 40.43% | 43.65% | 50.32% | 51.81% | 44.51% | 45.71% | 52.98% | |
| EPS YoY % growth | 0.64 12.28% | 1.85 189.06% | 2.77 49.73% | 3.20 15.38% | 3.89 21.75% | 4.95 27.11% | 5.40 9.14% | 4.47 -17.20% | 1.78 -60.22% | 1.97 10.71% | 2.35 19.17% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.73 33.56% | 0.77 18.37% | 0.82 18.92% | 0.86 -2.07% | 0.92 24.97% | 1.06 37.87% | 1.20 46.68% | 0.28 -68.04% | 1.06 15.56% | 1.09 2.88% | 1.13 -5.93% |
| Revenue Q2Q % growth | 619.87M 11.60% | 643.22M 13.19% | 668.62M 11.86% | 698.35M 16.65% | 708.05M 14.23% | 745.71M 15.93% | 794.03M 18.76% | 829.22M 18.74% | 881.22M 24.46% | 906.88M 21.61% | 939.36M 18.30% |
| EBITDA Q2Q % growth | 237.7M 22.40% | 262.02M 14.79% | 297.64M 6.89% | 301.75M 13.88% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 232.23M 24.28% | 246.9M 15.60% | 261.1M 1.85% | 266.3M 12.88% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.32%
EPS Next 5 Year
10.04%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
11.89%
Revenue Next 5 Year
6.37%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
20.09%
EBIT Next 5 Year
-5.79%
EXELIXIS INC / EXEL Forecast FAQ
When does EXELIXIS INC (EXEL) report earnings?
EXELIXIS INC (EXEL) will report earnings on 2026-05-06, after the market close.
What are the consensus estimates for EXELIXIS INC (EXEL) next earnings?
The consensus EPS estimate for the next earnings of EXELIXIS INC (EXEL) is 0.73 USD and the consensus revenue estimate is 619.87M USD.
What is the number of analysts for EXEL stock?
The number of analysts covering EXELIXIS INC (EXEL) is 27.